Label
Description
Diabetic Nephropathy
A Disease Or Phenotype
LOSARTAN indication Diabetic Nephropathy
A Knowledge Graph Assertion from IDG
1-(3-Mercapto-2-methyl-propionyl)-pyrrolidine-2-carboxylic acid indication Diabetic Nephropathy
1-(2-hydroxyethyl)-4-methyl-N-(4-(methylsulfonyl)phenyl)-5-(2-(trifluoromethyl)phenyl)-1H-pyrrole-3-carboxamide indication Diabetic Nephropathy
2-Butyl-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1,3-diaza-spiro[4.4]non-1-en-4-one indication Diabetic Nephropathy
PR001359
Despite recent advances, diabetic nephropathy (DN) remains a major public health concern. The precis...
SU003158
A subject from Metabolomics produced as part of the PR001894 project
SU004660
A subject from Metabolomics produced as part of the PR002828 project
SU004604
A subject from Metabolomics produced as part of the PR002805 project
PR000410
Diabetic nephropathy (DN) is the leading cause of end stage renal disease, and is associated with hi...